On Monday, Altimmune Inc (NASDAQ: ALT) was -4.66% drop from the session before settling in for the closing price of $3.86. A 52-week range for ALT has been $2.90 – $8.03.
A company in the Healthcare sector has jumped its sales by 3.48% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 27.05%. With a float of $103.61 million, this company’s outstanding shares have now reached $104.34 million.
Altimmune Inc (ALT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Altimmune Inc stocks. The insider ownership of Altimmune Inc is 0.71%, while institutional ownership is 40.02%. The most recent insider transaction that took place on Dec 29 ’25, was worth 2,003. In this transaction Director of this company bought 527 shares at a rate of $3.80, taking the stock ownership to the 527 shares. Before that another transaction happened on Dec 23 ’25, when Company’s Director bought 12,500 for $4.10, making the entire transaction worth $51,250. This insider now owns 12,500 shares in total.
Altimmune Inc (ALT) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.33 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.04% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
You can see what Altimmune Inc (ALT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 17.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19198.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 4.17 million. That was better than the volume of 3.6 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 3.45%.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 12.80%, which indicates a significant increase from 1.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.36 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.49, while its 200-day Moving Average is $4.61. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $3.80. Second resistance stands at $3.91. The third major resistance level sits at $3.99. If the price goes on to break the first support level at $3.61, it is likely to go to the next support level at $3.53. Assuming the price breaks the second support level, the third support level stands at $3.42.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are 104,342K outstanding shares of the company, which has a market capitalization of 383.98 million. As of now, sales total 20 K while income totals -95,060 K. Its latest quarter income was 10 K while its last quarter net income were -19,010 K.
